Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease liver disease
Phenotype C0040034|thrombocytopenia
Sentences 22
PubMedID- 24696622 Similarly, chronic liver disease patients with thrombocytopenia who need to undergo an invasive procedure may be potential candidates for short two-week courses of eltrombopag in the periprocedural period to help reduce the risk of bleeding.
PubMedID- 20919743 Given the fact that thrombocytopenia is associated with chronic liver diseases, and the multifunctional nature of platelets we reason that phenotype-specific platelets could be the systemic barometer for hepato-carcinogenesis.
PubMedID- 21131941 thrombocytopenia associated with chronic liver disease: effects of rifaximin on platelet count.
PubMedID- 26501978 Chronic liver disease is frequently complicated by thrombocytopenia (i.e., platelet count <150 × 109/l), which hampers the medical management of patients [1–5].
PubMedID- 26191473 We regarded a patient to have liver injury based on the following clinical data: (1) elevation of serum aspartate aminotransferase (ast) and/or alanine aminotransferase (alt) levels, or (2) the existence of primary liver disease associated with thrombocytopenia with platelet counts below 100,000/μl.
PubMedID- 24686514 These agents are currently in development for the treatment of thrombocytopenia in patients with chronic liver disease and liver cirrhosis [80–82].
PubMedID- 21637276 Small intestinal bacterial overgrowth and helicobacter pylori: can they be cause of thrombocytopenia in patients with chronic liver disease.
PubMedID- 25222481 The present review focuses on the etiologies and management options for severe thrombocytopenia in the setting of advanced liver disease.
PubMedID- 23339384 Correcting thrombocytopenia in patients with liver diseases: a difficult hurdle.
PubMedID- 24478597 It is stillcontroversial whether the thrombocytopenia observed in patients with chronic liver diseaseis more associated to splenomegaly or to very high portal blood pressure.
PubMedID- 24100055 Background: thrombocytopenia in patients with end-stage liver disease is a common disorder caused mainly by portal hypertension, low levels of thrombopoetin, and endotoxemia.
PubMedID- 24356057 Deterioration was associated with drooling, leukopenia, thrombocytopenia, splenomegaly and evidence of chronic liver disease.
PubMedID- 23086124 thrombocytopenia in patients with chronic liver disease: what's in a name.
PubMedID- 20565378 Despite prolonged coagulation times and thrombocytopenia associated with end-stage liver disease, formation of thrombi in the circulation seems to occur more frequently during liver transplant than during any other type of major surgery.
PubMedID- 22257364 Eltrombopag is not yet licensed for treatment of thrombocytopenia in patients with chronic liver disease because the risk of portal venous thrombosis (pvt) increased substantially when this drug was administered at 75 mg daily for 14 days [33].
PubMedID- 22674141 We evaluated the pharmacokinetics, efficacy, and safety of eltrombopag in japanese patients with thrombocytopenia associated with chronic liver disease (cld).
PubMedID- 24714308 No correlation between the size of the spleen and the amount of platelet specific immunoglobulin was found, and this may partly explain the inconstant relationship between the size of the spleen and the degree of thrombocytopenia in patients with chronic liver disease [9].
PubMedID- 20443100 Conclusions: our data suggest that partial splenic arterial embolization leads to an increase in platelet count in patients with thrombocytopenia due to chronic liver disease and hypersplenism.
PubMedID- 22054278 Romiplostim in chronic liver disease with severe thrombocytopenia undergoing an elective invasive procedure.
PubMedID- 20182351 Variables including acidosis, hypothermia, hypofibrinogenaemia, thrombocytopenia and model of end-stage liver disease (meld) score were not associated with clinical response to rfviia.
PubMedID- 26573200 [a case report of immune thrombocytopenia with drug induced liver disease].
PubMedID- 26459859 Overall the current study gives a better understanding of a novel approach to deal with thrombocytopenia associated with liver diseases with elevated ucb.

Page: 1